Agios Pharm (AGIO) — Cash Flow Quality Index
Agios Pharm (AGIO) has a Cash Flow Quality Index of -0.09x as of September 2024. Operating cash flow of $-84.22 Million is below net income of $947.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AGIO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Agios Pharm Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Agios Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Agios Pharm tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Agios Pharm (2024–2024)
Year-by-year earnings quality comparison for Agios Pharm. For live market cap and the full company financial profile, see Agios Pharm (AGIO) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.58x | $-389.84 Million | $673.73 Million | — |